| Identification |
| Name: | Hexadecanamide,N-[2-(3,4-dihydroxyphenyl)ethyl]- |
| Synonyms: | N-Palmitoyldopamine;N-Palmitoyl Dopamine; |
| CAS: | 136181-87-8 |
| Molecular Formula: | C24H41NO3 |
| Molecular Weight: | 391.59 |
| InChI: | InChI=1/C24H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-24(28)25-19-18-21-16-17-22(26)23(27)20-21/h16-17,20,26-27H,2-15,18-19H2,1H3,(H,25,28) |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 310.3°C |
| Boiling Point: | 589.5°Cat760mmHg |
| Density: | 1.006g/cm3 |
| Refractive index: | 1.514 |
| Biological Activity: | Endogenous fatty acid dopamide that displays 'entourage' effects on endovanilloids NADA and anandamide. Inactive at TRPV1 and CB 1 receptors (at concentrations up to 5 μ M) and does not inhibit AMT or FAAH (IC 50 > 25 μ M). However, potentiates TRPV1-mediated effects of NADA; lowers EC 50 from ~ 90 to ~ 30 nM. |
| Flash Point: | 310.3°C |
| Safety Data |
| |
 |
